08HH fundamentals
An in-depth look to SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD operating, investing, and financing activities
08HH free cash flow for H2 23 is -58.41 M EUR. For 2023, 08HH free cash flow was -284.69 M EUR and operating cash flow was 399.34 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM